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Abstract.  The SEC8 and SEC15 genes are essential 
for exocytosis in the yeast Saccharomyces  cerevisiae 
and exhibit strong genetic interactions with SEC4,  a 
gene of the ras superfamily. The SEC8 gene encodes a 
hydrophilic protein of 122 kD,  while the temperature- 
sensitive sec8-9 allele encodes a protein prematurely 
truncated at 82 kD by an opal stop codon. The Sec8p 
sequence contains a 202  amino acid region that is 
25 % identical to the leucine rich domain of yeast aden- 
ylate cyclase that has been implicated in ras responsive- 
ness.  Fractionation, stability, and cross-linking studies 
indicate that Sec8p  is a component of a  19.5S panicle 
that also contains Secl5p.  This panicle is found both 
in the cytosol and peripherally associated with the 
plasma membrane, but it is not associated with secre- 
tory vesicles.  Gel filtration studies suggest that a por- 
tion of Sec4p  is in association with the Sec8p/Secl5p 
panicle. We propose that this particle may function as 
a downstream effector of Sec4p,  serving to direct the 
fusion of secretory vesicles with the plasma membrane. 
T 
HE transfer of proteins from the ER, through the vari- 
ous  subcompartments  of the Golgi apparatus  to the 
cell surface, is mediated by carrier vesicles which faith- 
fully ferry the transported proteins from one organelle to the 
next along the secretory pathway. Since there are a number 
of organelles which can serve as vesicle donors and/or ac- 
ceptors the fidelity of  vesicular transport must be tightly reg- 
ulated to achieve this orderly flow. Genetic and biochemical 
approaches have been used to identify components that func- 
tion to regulate transport at each step of the secretory path- 
way (Rothman and Orci,  1992). In the yeast Saccharomyces 
cerevisiae genetic selections have defined a large number of 
gene  products  that function  within  the  secretory  pathway 
(Nakajima et al.,  1991; Newman and Ferro-Novick,  1987; 
Newman et al., 1990; Novick et al., 1980). A set of 10 SEC 
genes have been identified whose products function in trans- 
port from the Golgi apparatus to the plasma membrane (No- 
vick et al.,  1981). 
One of  the late-acting SECgene products, Sec4p, is a GTP- 
binding protein  of the ras superfamily (Salminen and No- 
vick, 1987) that is associated with both the cytoplasmic sur- 
face of secretory vesicles and the plasma membrane (Goud 
et al., 1988). A small soluble pool of Sec4p also is present 
in yeast. The cycle of GTP binding and hydrolysis by Sec4p 
is thought to be coupled to a cycle of localization in which 
Sec4p first associates with the membrane of secretory vesi- 
cles, exocytotic fusion then brings Sec4p to the plasma mem- 
brane and dissociation of Sec4p from the plasma membrane 
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allows recycling (Bourne,  1988; Walworth et al.,  1989a). 
This cycle may function to regulate the binding and fusion 
of secretory vesicles with the cell surface. By analogy with 
other GTP-binding proteins it is thought that the GTP-bound 
form of Sec4p interacts with an effector, thereby stimulating 
its activity and leading to exocytotic fusion. 
The yeast adenylate cyclase protein is the first identified 
downstream effector of a GTP-binding protein of the ras su- 
perfamily. In yeast, Raslp and Ras2p function through acti- 
vation of adenylate cyclase to regulate the intracellular level 
of cAMP, which in turn controls cell growth (Matsumoto et 
al., 1985; Mitts et al., 1990). Adenylate cyclase behaves as 
a large panicle and has been shown to associate with a 70-kD 
protein  encoded by CAP and the yeast GTPase-activating 
protein  Iralp  (Field  et  al.,  1988; Mitts  et  al.  1991).  A 
leucine-rich  repeat  domain  of adenylate  cyclase has been 
shown through in vitro mutagenesis to be required for Ras 
responsiveness (Colicelli et al., 1990; Field et al., 1990) and 
may define a site of direct physical interaction with Ras. 
The Sec4p effector is as yet unknown. However, the SEC4 
gene has been shown to genetically interact with a subset of 
the other late-acting SEC genes. Double mutants combining 
sec4-8 and sec2-41, sec5-24, sec8-9, seclO-2, or sec15-1 are 
lethal under conditions which are permissive to any of the 
single mutants (Salminen and Novick,  1987). The same set 
of mutants are partially suppressed by duplication of SEC4. 
The products of  these genes therefore are candidates for pro- 
teins that interact with Sec4p and one or more of these pro- 
teins may define the Sec4p effector. 
The  SEC15 gene  has  been  sequenced  and  its  product 
characterized  as a  ll5-kD protein that is located both in a 
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sociated with the plasma membrane (Bowser and Novick, 
1991). Overproduction of Secl5p results in impaired growth, 
accumulation of aggregated vesicles, and a patch of Secl5p 
seen by immunofluorescence (Salminen and Novick,  1989). 
The appearance of this patch of Secl5p upon overexpression 
is dependent on the function of Sec2p and Sec4p. These data 
suggested that Secl5p may act downstream of both Sec2p and 
Sec4p,  possibly  to  dock  secretory  vesicles to  the  plasma 
membrane  before  fusion.  The  subcellular  distribution of 
Secl5p is influenced by Sec8p function, as there is an appar- 
ent increase in the fraction of Secl5p found on the plasma 
membrane in sec8-9 mutant extracts  (Bowser and Novick, 
1991). This evidence suggested that Sec8p and Secl5p may 
interact. 
In this paper we report the sequence of the SEC8 gene, and 
the  characterization of the  Sec8  protein.  SEC8 encodes  a 
hydrophilic protein of 122 kD that is associated with Secl5p 
both on the plasma membrane and in a  19.5S soluble com- 
plex.  The  Sec8p  sequence  contains  a  region  that  shares 
similarity with the domain of adenylate cyclase necessary for 
Ras  responsiveness.  By  analogy,  this  suggests  that  Sec8p 
may respond to Sec4p. A portion of the soluble pool of Sec4p 
is found to co-elute with the Sec8p/Secl5p complex upon gel 
filtration.  This  complex  may  function as  the  downstream 
effector of Sec4p to regulate the binding and fusion of secre- 
tory vesicles with the plasma membrane. 
Materials and Methods 
Yeast Genetics 
s. cerevisiae  strains used in this study are listed in Table I. Cells were grown 
in YP medium  containing  1%  Bacto-yeast extract,  2%  Bacto-peptone 
(Difco Laboratories, Detroit, MI), and 2% glucose, or in minimal medium 
(SD) containing  0.7% yeast nitrogen base  without  amino acids  (Difco 
Laboratories) and 2% glucose, supplemented for anxotrophic requirements 
when necessary. 
Yeast transformation was generally performed by alkali cation treatment 
Table L  Yeast Strains 
Strain  Genotype 
NY13 
NY15 
NY17 
NY64 
NY410 
NY411 
NY580 
NY813 
NY862 
NY863 
NY864 
NY905 
NY906 
NY907 
NY910 
NY911 
NY912 
NY913 
MATa, ura2-53 
MATa, his4-619, ura3-52 
MATa, ura3-52, sec6-4 
MATa, ura3-52, sec15-1 
MATa, ura3-52, sec8-9 
MATe, his4-619, sec8-9 
MATa, 1eu2-3,112, ura3-52, pep4: :URA3 
MATa/ot, leu2-3,112/leu2-3,112, ura3-52/ura3-52, 
SEC8/sec8: :pNB338 (SEC8 disruption) 
MATa, NY13  +  pNB328 (Sec8  overproduced on YEp24) 
MATa, NY13  +  pNB329 (Sec8  on YCp50) 
MATa, NY410  +  pNB329 (Sec8  on YCp50 in sec8-9 
background) 
NY410  +  pNB305 (opal tRNA suppressor) 
NY410  +  pNB306 (amber tRNA suppressor) 
NY410  +  pNB307 (ochre tRNA suppressor) 
NY410  +  pNB139 (SEC4 on YCp50) 
NY410  +  pNB446 (sec8 BglII truncation) 
NY410  +  pNB447 (sec8 PstI truncation) 
NY410  +  pNB448 (sec8 NsiI truncation) 
(Ito et al., 1983), and transformants selected on SD medium, supplemented 
for additional auxotrophs as noted, at 25~ 
The SEC8 gene was cloned by complementation of the temperature- 
sensitive growth defect of sec8-9 cells with a yeast genomic DNA library 
contained in the high copy number vector YEp24 (Carlson and Botstein, 
1982).  100 A599 U of NY410 cells (sec8-9, uro3-52) were transformed 
with 800 ng of library DNA by the aiginic acid method (Vidoli et al., 1982) 
as follows: yeast spheroplasts were resuspended in 0.5 ml of 1 M sorbitol, 
10 mM "Iris, pH 7.5, 10 mM CaCI2, and incubated for 5 rain with 600 ng 
of DNA and 5 mi of 40% PEG containing 10 mM CaCl2 and 10 mM Tris, 
pH 7.5. The cells were then pelleted and resuspended in 450/~1 of 1.2 M 
sorbitol. 45 #1 were placed in a sterile tube, and an equal volume of 1.2 M 
sorbitol containing 4% alglnate was added. The suspension was plated on 
a SD medium containing 1.2 M sorbitol and 50 mM CaCI2. Ura  + transfor- 
mants were selected at 25~  and then replica plated to 370C on YPD plates. 
Total DNA was isolated from temperature  resistant  colonies. Approxi- 
rnately 50 ng of DNA was used to transform DHI cells and transformants 
selected on LB plates containing ampicillin. The plasmid DNA was then 
isolated from Escherichia coli cells and purified. 
Nucleic Acid Techniques 
E. coli strain DH1 (F-, recA1, endA1,  gyrA96, thi-1, hsdR17, supE44, relA1) 
was used for all cloning experiments. For production of fusion proteins to 
produce Sec8 antibodies, the SEC8  gene was first transformed into BU1255 
cells  (dam-) and further  subcloned in DH5cx cells (supE44, A/acU169 
[ep801acZAM15], hsdR17, fecal, endA1, gyrA96, thi-l, relA1) as described 
below. 
Plasmids used are listed in Table 1I. Plasmid pNB328 was isolated from 
a yeast genomic DNA library in the episomai vector YEp24 (Carlson and 
Botstein, 1982). pNB329, a centromere based plasmid containing SECS, 
was constructed by ligafing the gel purified 4.4-kb SmaI-SaiI fragment from 
pNB328 into YCpS0 as follows. YCp50 DNA was first digested with BamHI, 
filled in with Klenow,  pbosphatase  treated, phenol extracted, and  precipitated. 
This linear blunt-end DNA was then further digested with SaU and ligated 
to a gel purified 4.4-kb SmaI-SaiI fragment from pNB328. To construct 
pNB330, YIp5 DNA was digested with BamI-II  and SalI as described above 
for YCpS0 and ligated with the 4.4-kb SmaI-SalI fragment from pNB328. 
For disruption of the SEC8 gene, plasmid pNB338 was constructed by 
purification of a ll50-bp EcoRI-EcoRV fragment from pNB330 and liga- 
tion into SspI-EcoRI-digested YIp5. DHI cells were transformed with the 
ligation mix  and transformants selected  on LB containing  tetracycline 
plates.  Plasmids  were  isolated  and checked  for  the  proper  insertion. 
pNB338 was then digested with Xbal and used to transform the diploid yeast 
strain NY648 to disrupt one copy of the SEC8 gene. Transformants were 
selected on SD plates containing leucine at 25~  single colony purified, 
and sporulated.  The  resulting tetrads  were dissected and viable spores 
scored for the presence or absence of the Ura  + marker. 
Production of Sec8 Antibody 
A fusion between trpE and SEC8 was constructed using the pATHll vector. 
A 0.7-kb  EcoRI-XbaI fragment from pNB330 was ligated into EcoRI-XbaI- 
digested pATHI1. To do this BU1255 cells were transformed with pNB330 
to avoid methylation of the XbaI site within SECS. Plasmid isolated from 
this transformant was then digested with EcoRI-XbaI,  gel purified, and 
ligated into gel purified EcoRI-XbaI-digested pATHI  1 to produce pNB366. 
This ligation was transformed into DHSc~ cells, pNB366 encodes a TrpE- 
Sec8 fusion protein of 63 ltD. Fusion protein induction and isolation was 
performed as previously described (Saiminen and Novick, 1989), and rab- 
bit polyclonal antibodies produced from gel purified fusion  protein (Pocono 
Rabbit Farm, Canadensis, PA). Antiserum was collected after multiple sec- 
ondary injections. Affinity purification of the antibodies was performed as 
previously described (Goud et ai., 1988). 
DNA Sequencing and Analysis 
Nucleotide sequencing was performed by the standard dideoxy chain termi- 
nation method (Sanger et ai., 1977) using Sequenase (United States Bio- 
chemical,  Cleveland,  OH).  The samples were  electrophoresed  on 8% 
acrylamide gels containing 8 M urea. Single stranded template DNA was 
obtained by subcloning the BamHI-SaiI fragment of pNB330 into Blue- 
script (Stratagene, La Jolla, CA) and both strands were sequenced. 
The predicted protein sequence was compared with the National Bio- 
medical Research Foundation GenBank database, release number  68.0, June 
The Journal of Cell Biology, Volume 118, 1992  1042 1991, with the FASTA  program,  which performs a Pearson and Lipman ho- 
mology search (Pearson and Lipman,  1988). The GenBank accession num- 
ber for the SEC8 sequence is X64693, located in the EMBL data library. 
Cell Fractionation and Sec8p Localization 
NY13 cells were used for characterization and localization of Sec8p in wild- 
type cells.  Cell lysates were prepared  and used for Sephacryl S-500 gel 
filtration chromatography, sucrose velocity gradients, and sucrose density 
gradient as previously described (Bowser and Novick,  1991). SecSp local- 
ization was determined by immunoblot analysis using 8% polyacrylamide 
gels.  Proteins  were  transferred  onto  nitrocellulose  (BA  83,  0.22  #m; 
Schleicher & Schuell, Inc., Keone, NH) and Sec8p labeled with affinity 
purified antisera at 1/1,000 dilution for 2 h, washed, and subsequently la- 
beled  with  125I-Protein A  (0.5 #Ci/ml;  Amersham  Corp.,  Arlington 
Heights, IL) secondary antibody for 1.5 h. Individual bands were excised 
from the nitrocellulose and '25I-Protein A quantitated on a gamma counter. 
Enzyme assays were performed as previously described (Bowser and No- 
vick,  1991; Walworth et al.,  1989b). 
Immunoprecipitation 
NY580 cells (pep4::URA3)  were used for immunoprecipitation studies. 50 
A~0 U of cells were treated with Zymolyase 100T  for 45 min at 37"C to 
form spheroplasts. Spheroplasts were then lysed in 300 #1 of ice cold lysis 
buffer (PBS containing 0.1 M sorbitoi,  1 mM EDTA, 1 mM MgCI2, 1 mM 
PMSE  and  1/1,000 volume  of protease  inhibitor  cocktail:  leupeptin, 
chymostatin,  pepstatin,  aprotinin,  and  antipain,  each  at  1  mg/ml)  by 
resuspension and repeated pipetting until a homogeneous suspension was 
achieved. The following steps were performed at 4"C:  the lysate was cen- 
trifuged at 10,000 g for 10 min and the supernatant removed. For immuno- 
precipitation  from the membrane fraction, the pellet was first washed once 
in lysis buffer and the final membrane pellet resuspended in lysis buffer at 
a protein concentration  of 20 mg/ml, as determined by Bradford analysis 
(Bio-Rad Laboratories,  Cambridge, MA), and 50 #1 was used for immuno- 
precipitation  as follows: to the reaction tube containing 50/zl of superna- 
tant, 0.02 vol (or 0.04 vol) of dithio-bis-(succininfJdylpropionate)  (DSP) t, 
(Pierce Chemical Co., Rockford, IL.) was added and the samples incubated 
at 4~  for 30 min. 25 #1 of  0.4 M ammonium acetate was added to the tubes 
and incubated an additional 10 min to quench the reaction. SDS was added 
to 1% and the samples incubated at 65~  for 10 rain. After cooling on ice, 
700 #i of immunoprecipitation buffer (lysis buffer containing 1% TX-100) 
BSA to 0.1% were added. For immunoprecipitation in the absence of  cross- 
linker the samples were simply diluted with 700 #1 of immunoprecipitation 
buffer. All samples were first precleared by addition of 4 #1 of preimmune 
antisera and protein A-Sepbarose CIAB beads (Sigma Chemical Co., St. 
Louis,  MO),  followed by incubation for 30 rain and centrifugation  in a 
microcentrifuge for 30 s. The supernatant fraction was transferred to a fresh 
tube and either 8 #g of  aflinity purified ~-Sec8 antibody or a control rabbit 
IgG was added for overnight incubation at 4"C. The control IgG was a rabbit 
anti-mouse polyclonal serum,  which also recognizes a number of cross- 
reacting proteins in a yeast whole cell lysate. After 1 2-h incubation with 
protein  A-Sepharose CL4B  beads  at 4*C, the beads  were  collected  by 
microcentrifugation  for 15 s. The beads were washed once with immuno- 
precipitation buffer containing 0.2 % SDS (IPS buffer) and then twice with 
IPS containing 2 M urea, twice with IPS containing 0.5 M NaC1, and once 
with IPS.  For immunoprecipitation  under  native conditions the antibody 
was added to the reaction tube in the absence of detergents and after over- 
night incubation the immune complexes collected as above. The beads were 
washed five times in lysis buffer containing 0.5 M NaC1. Antigens were 
released from beads by heating in SDS-PAGE  buffer for 5 min at 100*C and 
loaded onto 8 % SDS-polyacrylamide  gels. 
Results 
Cloning and Characterization of the SEC8 Locus 
The SEC8 gene was cloned by complementation of the tem- 
perature sensitive seeS-9 allele using a yeast genomic DNA 
library in the high copy number vector YEp24. NY410 cells 
1.  Abbreviation  used in this paper:  DSP, dithio-bis-(succinimidylpropi- 
onate). 
(MAT~, secS-9,  ura3-52) were  transformed  and  ,,07,500 
Ura  + transformants were selected at 25~  and then replica 
plated onto YPD plates at 37~  Plasmid DNA was isolated 
from temperature resistant colonies, amplified in E. coli and 
re-introduced into secS-9 cells. Plasmids that complemented 
the secS-9 growth defect were analyzed by restriction diges- 
tion and the smallest plasmid, pNB328, (Table II) was used 
for further studies. 
Analysis of  plasmid pNB328 revealed a genomic DNA in- 
sert of 3.8 kb (Fig. 1 a). The ability of this insert to comple- 
ment sec8-9 cells at single copy was tested by ligating a 4.4- 
kb  SmaI-SalI  fragment,  which  contains  the  complete 
genomic insert, into the centromere based vector YCp50. In- 
troduction of this plasmid, pNB329, into secS-9 cells fully 
restored growth at 37~  Various restriction fragments were 
subcloned into YCp50 and analyzed for complementing ac- 
tivity (Fig. 1 a). The smallest fully complementing fragment 
contains all but ,,o400 bp of the original genomic isolate and 
is contained in a San3A-NsiI fragment of 3,344 bp. 
To determine if the cloned fragment represents the SEC8 
gene, the ability of the sequence to direct integration into the 
SEC8 locus was analyzed. The 4.4-kb SmaI-SalI fragment 
of pNB328  was inserted into the yeast integrating vector, 
YIp5,  which contains the  selectable marker  URA3. This 
plasmid, pNB330, was cleaved within the complementing re- 
gion by digestion with BglII and introduced into the wild 
type haploid yeast strain, NY15 (MATa, ura3-52). Integra- 
tion at the SEC8 locus results in the duplication of the cloned 
sequence, with the URA3 marker between the two copies. 
This transformant was mated with NY410 (MATa, see8-9, 
ura3-52) and the resulting diploid was sporulated and ana- 
lyzed by tetrad dissection. If the cloned sequence represents 
the SEC8 gene, then the Ura  § and Ts  § phenotypes should 
co-segregate. Of 36 tetrads analyzed, 34 segregated 2 Ura  § 
Ts+:  2  Ura-  Ts-  (Table  III).  No  Ts-,  Ura  + spores  were 
found, yet in two tetrads Ura-, Ts  § spores were seen, possi- 
bly the result of gene conversion events. The tight linkage ob- 
served between the sec8-9 locus and the site of plasmid in- 
tegration supports the conclusion that the cloned sequence 
represents the SEC8 locus. 
SEC8 Sequence 
Having localized the smallest complementing region of the 
SEC8 gene to a 3.34-kb fragment the nucleotide sequence of 
this region was  determined.  A  single large open reading 
frame was found that continued without a stop codon to the 
NsiI site. Therefore DNA sequencing was continued beyond 
the site and a stop codon 192-bp downstream from the NsiI 
restriction site was discovered (Fig. 2 a). That the 3.34-kb 
Sau3A-NsiI fragment fully complements the sec8-9 muta- 
tion suggests that the extreme carboxy terminus of the See8 
protein is dispensable. The DNA sequence identifies an open 
reading frame of 3,197 bp (Fig. 2 a).  Upstream of the pro- 
posed initiation codon, at position -99, is a TATA sequence 
element. The open reading frame is terminated by a TGA 
stop codon, which is followed by six additional termination 
codons within the next 20 potential codons. This open read- 
ing frame predicts a protein of 1,065 amino acids with an es- 
timated molecular mass of 122 kD. The predicted amino acid 
sequence  is  hydrophilic and  does  not  contain  either  an 
NH2-terminal signal sequence or any potential membrane 
spanning domains. 
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Figure I. (A) A restriction map 
of the sec8-9 complementing 
region. Plasmid pNB328 was 
isolated from a yeast genomic 
library in the high copy number 
vector  YEp24.  The plasmid 
pNB329  contains  the  entire 
genomic  sequence  inserted 
into the centromere based vec- 
tor YCp50. The plasmid pNB- 
330 contains the entire  genomic 
sequence inserted into the in- 
tegrating vector YIp5. Various 
fragments were also subcloned 
into the centromere based vec- 
tor and tested for complemen- 
tation of the growth defect of 
a sec8-9  mutant  at  34  ~ and 
37~  as  shown. The  Sec8p 
open reading frame is shown 
as a bold arrow. The molecu- 
lar weights of the proteins en- 
coded by the SEC8 gene and 
the  various  truncations  are 
listed. The predicted weights 
of the truncations account for read through into vector sequence. The molecular weights measured by immunoblot analysis are also listed. 
The plasmid pNB366 encodes a fusion of TrpE to the indicated region of See& The plasmid pNB338 consists of an integrating vector 
carrying an internal fragment of SEC8. The restriction enzymes are as follows: S, Sau3A; E, EcoRI; H, HindM; X, XbaI; EV, EcoRV; 
B, BgllI; P, PstI; N, NsiI. Not all sites for these enzymes are shown. (B) Integration of pNB338 into the SEC8 locus results in disruption 
of the gene. A partial duplication is formed in which one copy is truncated at the EcoRV site and the second copy lacks a promoter as 
well as the start of the SEC8 gene. 
A  search  for  sequence  motifs  using  the  Wisconsin 
Genetics Computer Group package Motifs program (GCG 
Inc., Madison, WI) revealed a leucine-rich domain (10 leu- 
cine residues in 40 amino acids) containing a possible leu- 
cine  zipper  motif near the  NH:  terminus  of the  protein 
(Fig. 2 a). However, a proline residue is present within this 
domain which may disrupt the alpha-helical characteristic 
of leucine  zipper  binding  domains.  Comparison  of the 
predicted protein sequence with those in the GenBank data- 
base by the GCG FASTA program revealed a 189 amino acid 
region of Sec8p that shared 21.2% identity with a 185 amino 
acid domain of the yeast adenylate cyclase protein, encoded 
by the  CYR/  gene.  This region of similarity includes the 
leucine-rich domain of Sec8p and a leucine-rich domain of 
adenylate cyclase. Comparison of this 185 amino acid leu- 
cine-rich domain of  adenylate cyclase to the Sec8p sequence 
using the GCG BESTFIT  program revealed a 202 amino acid 
region of Sec8p with 25.4% identity and 44% overall homol- 
ogy (Fig. 2 b). Mutational analysis of adenylate cyclase has 
demonstrated that this leucine rich region is required for ac- 
tivation by RAS (ColiceUi et al.,  1990; Field et al.,  1990). 
By analogy, the leucine rich domain of Sec8p may provide 
a site for protein-protein interaction with the ms-related pro- 
tein Sec4p. 
To determine the significance of  this similarity, we shuffled 
the Sec8p sequence using the BESTFIT program 300 inde- 
pendent times and compared each with the domain of  adenyl- 
ate  cyclase.  If  the  similarity  is  significant,  then  upon 
shuffling the percentage of identity should decrease.  The 
results are recorded as a measurement of quality points for 
each comparison and the overall results reported as the aver- 
age quality point value -t- the standard deviation. The initial 
quality point value for the comparison of Sec8p and adenyl- 
ate cyclase is 77.1. After sequence shuffling the average qual- 
Table II. Plasmids Used in Study 
Ptasmid  Derivation 
pNB328 
pNB329 
pNB330 
pNB338 
pNB366 
pN~46 
pNB447 
pNB448 
YEp24, SEC8, 4.4-kb genomic library insert 
YCp50,  SEC8, 4,4-kb SmaI-SalI fragment  from pNB328  into SmaI-SalI-digested YCp50 
YIpS, SEC8, 4.4-kb SmaI-SalI fragment from pNB328 into SmaI-SalI-digested YIp5 
YIp5, 1.15-kb EcoRI-EcoRV fragment from pNB330 into SspI-EcoRI-digested YIp5 
pATH11, TrpE-SEC8 fusion; 0.7-kb EcoRI-XbaI fragment from pNB330 into EcoRI-XbaI-digested  pATH11 
YCp50, 2.32-kb Sau3A-BgllI fragment from pNB330 into Sau3A-BglII-digested YCp50 
YCp50, 2.59-kb Sau3A-PstI fragment from pNB330 into Sau3A-Pstl-digested YCp50 
YCp50, 3.34-kb Sau3A-NsiI fragment from pNB328 into Sau3A-NsiI-digested YCp50 
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NYI5/PNB330 (MATt his4-619, ura3-52, SECS::SECS, URA3) 
￿ 
NY410 (MATa ura3-52, sec8-9) 
2  Tetratype:  2  Ura§  +,  1 Ura-Ts §  1 Ura-Ts- 
34 Parental ditype:  2  Ura+Ts  §  2  Ura-Ts- 
0  Nonparental ditype:  2  Ura+Ts §  2  Ura-Ts + 
ity point value is 65.3 +  3.3. The significance of these values 
can be expressed as the z value where 
z  =  (initial quality score  -  average quality score 
after randomization)/SD 
The z value of this comparison is 3.6. A z value between 3 
and 6 indicates the comparison is possibly significant (Lip- 
man and Pearson,  1985). Therefore the significance of this 
similarity must be considered speculative.  Since both se- 
quences are rich in leucine residues, even after shuffling the 
sequences will  still contain a  disproportionate number of 
leucine residues that may artificially elevate the randomized 
quality score. Another criteria to consider is the number of 
times,  among  the  shuffled  comparisons,  that  the  quality 
score is  equal to or greater than the  initial  quality score 
(Pearson and Lipman,  1988). In comparisons between 300 
shuffled Sec8p sequences and adenylate cyclase, no random 
quality scores were equal to or greater than the initial quality 
score. 
SEC8 Encodes an Essential Gene Product 
A null allele of SEC8 was constructed to determine if Sec8p 
function is required for cell viability. Plasmid pNB338 con- 
tains an internal EcoRI-EcoRV fragment from pNB330 in 
YIp5. This plasmid was cleaved within the SEC8 sequence 
by digestion with XbaI and used for transformation. Integra- 
tion of this plasmid into NY648 cells, a diploid homozygous 
for the ura3-52 mutation, should result in the disruption of 
one chromosomal copy of SEC8 by generating a duplication 
in which both copies of SEC8 are truncated (Fig. 1 b). Trans- 
formants were selected at 25~  on minimal plates containing 
leucine, and single colonies were sporulated and dissected. 
All 24 tetrads analyzed yielded two viable spores that were 
Ura- and two inviable spores. This result implies that this 
putative null allele of see8 is a recessive lethal mutation and 
that the SEC8 gene is an essential locus. 
Double Mutants of  sec8-9 and Late-acting sec 
Mutants Are Lethal 
In a previous report we demonstrated that sec4-8 is lethal in 
combination with a subset of late-acting sec mutants, includ- 
ing  sec8-9  (Salminen  and  Novick,  1987).  To extend this 
genetic analysis, seeS-9 was crossed with representative al- 
leles of all other sec complementation groups. The diploids 
were sporulated, tetrads dissected, and germinated at 250C. 
In  crosses  with  all  of the  late-acting sec  mutants  except 
secl-1, lethality was observed in approximately one-fourth of 
the meiotic products (Table IV). The pattern of inviability in- 
dicates that it is the combination of sec mutations that is le- 
thal. Complementation analysis was performed on the viable 
spores and verified that the inviable spores were double mu- 
tants. In the cross with see1-1, all meiotic products were via- 
ble at 25~  but double mutants were inviable at 30~  a tem- 
perature at which either secl-1 or sec8-9 alone are viable. As 
in the case of sec4-8,  sec8-9 is also lethal in combination 
with sec19-1 and bet2-1 (Table IV). While the bet2-1 mutant 
displays an ER-blocked phenotype, the BET2 gene product 
has been shown to function in the membrane attachment of 
both Yptlp and Sec4p (Rossi et al., 1991). The lethality seen 
in double mutants of  sec8-9 and bet2-1 may be a consequence 
of a defect in Sec4p function (Rossi et al., 1991). SEC19 may 
function at several points in the secretory pathway as the 
sec19-1  mutant  accumulates  intermediates  indicative  of 
blocks at the ER to Golgi, Golgi, and post-Golgi stages of 
the pathway (Novick et al.,  1981). 
Since overexpression of Sec4p suppresses the growth de- 
fect of a subset of late-acting sec mutants, including sec8-9, 
the ability of Sec8p overexpression to suppress the growth 
defects of late-acting sec mutants was tested. Late-acting sec 
mutants were transformed with pNB328, the multicopy plas- 
mid containing SEC8, and tested for the ability to grow at 
37~  It was  found that overexpression of Sec8p failed to 
suppress the growth defects of any other late-acting sec mu- 
tants. 
Generation of  Antisera Against Sec8p and 
Identification of the Protein 
To identify and characterize the See8 protein, polyclonal an- 
tisera was generated against a TrpE-Sec8 fusion protein. A 
0.7-kb EcoRI-XbaI fragment of SEC8 encoding a peptide se- 
quence predicted to be hydrophilic in nature was fused in 
frame to TrpE in the pATHll vector. This construct encodes 
a 63-kD fusion protein that was gel purified and used to im- 
munize rabbits. By immunoblot analysis of  yeast cell lysates, 
this polyclonal antibody (c~Sec8p) recognizes a protein of 
~122 kD (Fig. 3 a). To confirm that this protein represents 
the SEC8 gene product, we transformed NY13 cells with the 
original high copy number SEC8 clone (pNB328) to over- 
produce the protein. Immunoblots of lysates from cells con- 
taining this plasmid (NY862) showed an amplification of the 
122-kD band and the appearance of multiple bands of lower 
molecular weight, which may reflect degradation products of 
the overexpressed protein. This demonstrates that the anti- 
body recognizes Sec8p. Analysis of a see8-9 strain, NY410, 
revealed that the mutant protein was shifted to a higher mo- 
bility and was present at a somewhat reduced level relative 
to the wild type protein (Fig. 3 a, lane 6vs. lane 2). To deter- 
mine if the seeS-9 mutation causes a premature termination 
of the protein, secS-9 cells were transformed with plasmids 
carrying various tRNA suppressor genes.  Cells containing 
an opal tRNA suppressor expressed a significant quantity of 
native molecular weight SecSp, 122 kD, at 25~  (Fig. 3 a, 
lane 3). The presence of the opal tRNA suppressor also al- 
lowed growth of sec8-9 cells and expression of full-length 
Sec8p at 37~  (Fig. 3 a, lane 8). Cells containing the amber 
and ochre tRNA suppressors failed to synthesize full length 
protein (Fig.  3 a, lanes 4 and 5) and also failed to rescue 
growth at 37~  Therefore the see8-9 mutation results in a 
premature opal stop codon. 
To determine the approximate location of the stop codon 
in the see8-9 gene COOH-terminal truncations of  SEC8 were 
subcloned into YCp50 and introduced into seeS-9 cells. Im- 
munoblots were performed on lysates tO determine the ap- 
parent molecular mass of each truncated protein. The con- 
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-300  GAATTC  AATGTCCAAATTAAGAGC  TACT  TGGTTG  AAGAAGT  GA~TT  TCAAAACCGATTTGTCC  TCCTCG  TCTTATAGTAAC  CA~AC  -219 
-216  AC~TA~T&T~TCATGAAGTTATATTCTGACC~T  ~AATTCT  TCT  TTCTTTGACGTA~ACTTT&TGG~TAACGCTCAAATAGTT  -129 
-129  TCTTGTTAACC&TTTCAAATAACAATAAGTA  TACAAC  TAAACAAAGTC  TGCTACTTGTTAATATAGGAGTATAAAC  AAGATAA~T~T  -39 
-30  ACTTTTTCAGCACAACCGCCACC  TCTCGATT  GCATACAATGGATTACC  TAAAACC&GCGCAGAAGGGGAGAAGAt'GTGG~T~AT~  31 
M  D  Y  L  ~  P  A  Q  K  G  R  R  R  G  L  S  I  N 
52  ACAGTCTTTCGGAGACTCAGCAATCTGCTATGAATAGTTCCCTGGACCATCTTCA~AATGACTTAAAcAGGATA~ATCTTCAATGGAATA  141 
S  L  S  E  T  Q  O  S  A  M  N  s  S  L  D  H  t  o  N  D  L  W  R  !  N  L  O  W  N  R 
142  GAATACTGTCGGATAACACTAATCCCTTAGAACTAGCGCTCGCATT  TTTGGATGATACATCTGTAGGTCTGGGCCACCGGTATGAAGAAT  231 
I  L  S  ?1  N  T  tl  p  L  ~.  L  A  L  A  F  L  D  D  ?  S  V  C.  L  G  H  R  Y  E  E  F 
232  TCAATCAATTAAAGTCACAAATTGGTAGTCACTTACAAG•TGTTGTT••TGAACATAGCCAAGTGTTCAACACTAATGTGGCTTCTTACG  321 
N  Q  L  K  S  0  I  G  S  H  L  O  D  V  V  N  E  H  S  Q  V  F  N  T  N  V  A  S  Y  G 
322  G~GCAGTC  AGTTCGA  TCATGCAGGCCC  AAGAAC  AGACTT  TA~ T  C  TGA~ATTGT  T  TAAAGGAAGC  TAAT  GAG~TCACCACTG  411 
K  A  V  S  S  I  M  O  A  Q  E  Q  T  L  N  L  K  N  C  L  K  E  A  N  E  K  I  T  T  D 
412  ATAAAGGTTCTTTACAGGAATTAAATGATAAT&ACT  TGAAGTATACAAAAATGATTGATGTTTTAGTCAATATTGAGGAGTTATTACAGA  501 
K  G  S  L  O  E  L  N  D  N  N  L  K  Y  T  K  M  I  D  V  L  V  N  I  E  E  L  L  Q  I 
502  TACCCGAAAAAATTGAGGAGAACATTAGAAAGGAAAATTTCCATCAGGTGCAAATTCTCCTAGAAAGGGGTTTCATATTAATGAACAACA  591 
P  E  K  I  E  E  N  I  R  K  E  N  F  H  Q  V  0  I  L  L  E  R  G  F  I  L  M  N  N  K 
592  AATCTTTGAAGACAGTGGAGATTTTAAAGCC  TATAAACCAACAACTTGAGTTACAAGAACATTTACTTTTCAACAATCTGATTGAAGAAA  681 
S  L  K  T  V  E  I  L  K  P  I  N  Q  Q  L  E  L  O  E  H  L  L  F  N  N  L  I  E  E  I 
682  TTCACGACATTATGTAC  TCCAAATCTAACAAAACAAATTTTACTCGAGTAACCAATAATGATATATTC.%AAATCATAAGCATTTCACATA  771 
H  D  I  M  u  8  K  S  N  K  T  N  F  T  R  V  T  N  N  D  I  F  K  I  I  S  I  S  H  N 
772  ATGGATTTACGAGTTTAGAAAATTACCTGTACAACATAGTCAATATTGATATTATGGAA~ACTCAA~AACGATAAACAAGAACCTTGAAC  061 
G  F  T  S  L  E  N  Y  L  Y  N  I  V  N  I  D  I  M  E  H  S  K  T  I  N  K  N  L  E  Q 
862  AATTCATTCATGACCAATCGTTAAATAAAGGAAATATCATGCTAC AAGAAAATGC  TGCGACTCAAGCACCAT TGGCACCATCTAGAAACC  951 
F  I  8  D  Q  5  L  N  K  G  N  I  M  L  Q  E  N  A  A  T  Q  A  P  L  A  P  $  R  N  Q 
952  AAGAAAACGAAGGATTTAACAGAATAGGGTTCCT  ACTAAAAACCATAAATAACATCAATAAATTACCTGTTGCATTCAATATAATAACAG  1041 
E  N  E  G  F  N  R  I  G  F  L  L  K  T  I  N  N  I  N  K  L  P  V  A  F  N  I  I  T  E 
1042  AAAGGGCTAAAGAGGAGATTCATAATATAATTGT TAAAAGTACCGAATCAATACGTTCGAAGCACCCTTCTCTGCTTAAAATGGCTACTA  1131 
R  A  K  E  E  I  H  N  I  I  V  K  8  T  E  S  I  R  S  K  H  P  S  L  L  K  M  A  T  S 
1132  GTTTAAAGAATGACAACCATT  TTGGCCTACCCGTACAGGATATACTATCGATCATTTTAAGGGAATGCTTTTGGGAAATATTTTTGAAAT  1221 
L  K  N  D  N  H  F  G  L  P  V  Q  D  I  L  S  I  I  L  R  E  C  F  W  E  I  F  L  K  L 
1222  TACTGTATGCTATTCAGTGCCATAGGGC  TATTTTTGAAATGTCAAACATTTTGCAGCCAACGTCTTCCGCAAAGCCAGCTTTCAAGTTCA  1311 
L  u  A  I  Q  C  8  R  A  I  F  E  M  8  N  I  L  Q  P  T  S  S  A  K  P  A  F  K  F  N 
1312  ATAAAATTTGGGGCAAACTGTTAGATG  AAATAGAAT  TAT  TAC  T  TGTGAGGTACATCAATGACCC  TGAATTGATATCCAGCAATAACGGTA  1401 
K  I  W  G  K  L  L  D  E  I  E  L  L  L  V  R  Y  I  N  D  P  E  L  I  S  S  N  N  G  S 
1402  GTATTAAACCAATTAATGGCGCGAC  AAATAACGC  ACCCACTT  TACCTAAAAGGAAAAATCC  TAAAATTTTTTCTTTGGAGTATAACATTG  1491 
I  K  P  I  N  G  A  T  N  N  A  P  T  L  P  K  R  K  N  P  K  I  F  S  L  E  Y  N  I  E 
1492  AGGACAATTCTTC  TGTAAAGGATCAAGCTTT  TGAACTAAAGGCTTTGTTGAAAGATATATTCCCTGGATTTTC  TGTCTCCTCAAACATGG  1581 
D  N  S  S  V  K  D  Q  A  F  E  L  K  A  L  L  K  D  I  F  P  G  F  S  V  S  S  N  M  D 
1582  ATTTAGACTCTATTTATGTAAAAGATGAATCCTTCGAACAAGATGAGCCTCTAGTCCCT~CTTCTGTTTTCAA~ATGAAGGTAATTTTAG  1671 
L  D  S  I  Y  V  K  D  E  S  F  E  Q  D  E  P  L  V  P  P  S  V  F  N  M  K  V  I  L  D 
1672  ATCCGTTTTTGCTGT  TTACGCAATCGACATCTACAATTGTTCCCAG  TGTCTTAACACAAAATACTATTTCATCCCTAACCTTTTTCGATG  1761 
P  F  L  L  F  T  Q  S  T  S  T  I  V  P  S  V  L  T  Q  N  T  I  S  S  L  T  F  F  D  D 
1762  ATTATATGAATAAAAGTTTTCTCCC  AAAGATTCAGATGACTATGGAT  TATTTATTCACGGT  TGAAGTAGAATCCAATAATCCGTACC,  CCT  1851 
Y  M  N  K  S  F  L  P  K  I  Q  M  T  M  0  Y  L  F  T  V  E  V  E  5  N  N  P  u  A  L 
1852  TAGAGCTATCCGATGAAAATCATAACATTTTTAAAACAGCATTAGATTTT~%AGGTTATTTTACAATTTAT TGAATGT  TTTCAACAC~  1991 
E  L  S  D  E  N  H  N  l  F  g  T  A  L  ~  F  Q  R  L  r  Y  N  L  L  N  V  F  N  T  A 
1942  CAAACACATTTAGAGAAAAAAT  ATCGTACTGCATTC  TAGATCTTT  TGAATCATTTTTATAATTAC  TACTTGGGGCTATTTAATTCCTTGA  2031 
N  T  F  8  E  K  I  S  Y  C  I  L  D  L  L  N  H  F  Y  N  u  u  L  G  L  F  N  S  L  I 
2032  TTGGTACTTCTGATAGAC  ATT  T  AACTAGGAAAATAATTACGGC  ATGG  TTGCAGAATGGTATTTTGATGGATCA~CA~TTCTGA  2121 
G  T  S  D  R  H  L  T  R  K  I  I  T  A  W  L  Q  N  G  I  L  M  D  Q  E  Q  K  I  L  N 
2122  ATGGGGATGAGACACTCTT  TC  ATG  AAGAATCCATAGAGTT  ATTTAAGGAAATACC  TCATTTCTATCAAGCGGGTAAAGGTTTGAGCAAAT  2211 
G  P  E  T  L  F  8  E  E  $  I  E  L  F  K  E  I  P  H  F  Y  Q  A  G  K  G  L  8  K  S 
2212  CTGATTTATTCAATAACTTGACATTGGACAC  AATTCTGCAGTTTTCGGCAAGCGTGTTATGGATATTAAACTGGCTGCCAGGCTTAAAAA  2301 
D  L  F  N  N  L  T  L  D  T  I  L  Q  F  S  A  5  V  L  W  I  L  N  W  L  P  G  L  K  K 
2302  AGGCTATCAATATTGATGAAGTAAGCCAAGAACCCATGTTAGATGCTGATAGATTAAGGAGCAGCTGGACATTT  TCTGAATCAATGGATT  2391 
A  I  N  I  D  E  V  S  Q  E  P  M  L  D  A  D  R  L  R  S  S  W  T  F  S  E  S  M  D  L 
2392  TAAACTATTCGAACCCTAGTTCC  AGCCCAAATTCATTAGGAAATC  TAAAAATTTTATTGGATGATAAAGCCTCCAAAAAATTTGATGAGA  2481 
N  Y  S  N  P  S  S  S  P  N  S  L  G  N  L  K  I  L  L  D  D  K  A  S  K  K  F  D  E  T 
2402  CTATCGACGGATTCAAAACCTTG  AAAT  TCAAACTAATCACTATACTGAGGTTCAACATTAGGGCCTTGTGTATATACGACATCGGGTCTT  2571 
I  D  G  F  K  T  L  K  F  K  L  I  T  I  L  R  F  N  I  R  A  L  C  I  Y  D  I  G  S  F 
2572  TTTTTCAAAACACCAAAATTTGGAATATGGATGTGGGTAGTATTGAATTAGAT•AAAATATAGCTTCTCTAATTTCCGAATTAAGAAGGA  2661 
F  Q  N  T  K  I  W  N  M  D  V  G  S  I  E  L  D  (~  N  I  A  S  L  I  S  E  L  R  R  T 
2662  CTGAAAGCAAATTGAAACAACAGT  TACCAGAAAAGGAAAAAAACTCCATATTTATTGGTCTTGATATAGTCAACAACTACGCCTTGATTA  2751 
E  $  K  L  K  O  Q  L  P  E  K  E  K  N  S  I  F  I  G  L  D  I  V  N  N  Y  A  L  I  K 
2752  AGGGTGCCAAATCCATAAAAGTT  TTGAACCATAACGGGATAAAGAAAATGTTGAGAAATGTAAATGTCTTACAACATGCCTATAGAAATC  2841 
G  A  K  S  I  K  V  L  N  H  N  G  I  K  K  M  L  R  N  V  N  V  L  Q  S  A  Y  R  N  L 
2842  TTTCTTCTGAACCATCAAAAAT  TAATATGAACGTCACAATGAATTTTTACTCTTTATGCGGC  TCCAGTGAAGCTGAACTATTTGAATATA  2931 
S  $  E  P  S  K  I  N  M  N  V  T  M  N  F  Y  S  L  C  G  S  S  E  A  E  L  F  E  Y  I 
2932  TAAAAGACAATGAATTACCGCATTGTTCTGTCGAAGATT  TGAAAACCATATTGAGGCTGCAGTTTAGCGAGGAAATGCATCGTCAATTGA  3021 
K  D  N  K  L  P  H  C  S  V  E  D  L  K  T  I  L  R  L  Q  F  S  E  E  M  H  R  Q  L  K 
3022  AGAGACAAAGCACTAGCTCAAC  TAAGGGTTCCATAAAACCTTCCAATAAGAGGTACACTGAAGCTTTGGAGAAACTAAGTAACCTCC4%%A  3111 
R  Q  S  T  S  S  T  K  G  S  I  ~  P  S  N  K  R  Y  T  E  A  L  E  K  L  S  N  L  E  K 
3112  AAGAGCAGTCGAAAGAAGGAG~CCGCA~CAAGATT~GAAAACTTAAAAGCAAATTGAATGCTGTCCATACTGCAAACGA~TGACATT  3201 
E  Q  S  K  E  G  A  R  T  K  I  G  K  L  K  S  K  L  N  A  V  H  T  A  N  E  K  * 
3202  TTTAGTTTGTGTAAAATTAAT  TTGATAAATAAATGAATGAAAATGATCAATAATAAGCGAATAAGTATATTTTTAATTAGGTTATTTTTA  3291 
3292  GAATATTTTCACTTGCACTTATTTATTTCAGCGCGCCAGGTCGTC  TTGTCTGTGGAATCAAGATACCTGAAGGAACATTACACATCAATC  3381 
3382  AACACTTGAGGTAGGAATATA~ACGATCCTCTA~GCCGGACGCATCGTGCCGGCATCA~GCGGCACAGGTGCGGTGTCGGCGCTTATAT  3470 
Figure 2. Nuclcotide sequence 
of SEC8.  (A)  The  DNA  and 
amino  acid  sequence  of  the 
SEC8 open reading  frame are 
shown.  The  C-enBank  data- 
base  accession  number  of 
SEC8 is X64693.  The leucine 
rich domain is underlined.  (B) 
A  202  amino acid  region of 
Sec8p containing the leucine 
rich  domain  exhibits  25.4% 
identity and 44 % similarity to 
a  185  amino acid domain of 
adenylate  cyclase.  Identical 
amino acids arc distinguished 
by a "I"  and conserved amino 
acids with a "*."  The homol- 
ogy  search  between Scc8p  and 
adenylate cyclase was  per- 
formed using the Wisconsin 
Genetics  Computer  Group 
BESTFIT program. (C) The 
region of adenylate cyclase 
that exhibits  homology with 
SecSp is contained within the 
leucine repeat domain of aden- 
ylate cyclase. B 
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Table IV.  Summary  of Genetic Interactions  between sec8 
and  Other sec  Genes 
sec8-9 
x  C,  enotype  Viability of double mutant 
NY3  secl-1  (+) at 25~  (-) at 30~ 
NY 130  sec2-41  - 
NY412  sec3-2  - 
NY405  sec4-8  - 
NY402  sec5-24  - 
NY 17  sec6-4  - 
NY57  secg-4  - 
NY61  sec10~2  - 
NY64  seclS-1  - 
NY756  sec7-1  + 
NY728  secl2-4  + 
NY414  secl3-1  + 
NY415  secl 6-2  + 
NY418  secl 7-1  + 
NY431  sec18-1  + 
NY420  sec19-1  (+) at 25~  (-) at 300C 
NY422  sec20-1  + 
NY423  sec21-2  + 
NY426  sec22-2  + 
ANY114  bet1-1  + 
ANY120  bet2-1  - 
NY806  sec23-1  + 
structs  used  and the  size of the resulting  polypeptides  are 
depicted in Fig.  1 a. Truncation at the NsiI site results in a 
loss of 60  amino  acids  from the  protein  and  sec8-9 cells 
transformed  with  a  plasmid  containing  this  truncation, 
pNB448, are fully complemented at 37~  and express a See8 
protein with an apparent molecular mass that is ,02 kD less 
than that of the wild type protein (Fig.  1 a). A truncation at 
the PstI site, pNB447,  allows complementation to 34~  a 
temperature that is otherwise lethal to sec8-9 cells, but will 
not restore growth at 37~  Analysis of this truncated protein 
by immunoblot revealed a band of 84 kD (Fig.  1 a). Further 
truncation at the BglII site (Fig. 1 a) also fails to complement 
the sec8-9 mutation at 37~  but does suppress at 34~  This 
truncated protein has a higher mobility on SDS-polyacryl- 
amide gels than the mutant Sec8-9 protein, and corresponds 
to a  molecular weight of 78 kD (Fig.  1 a).  These COOH- 
terminal truncations have roughly mapped the sec8-9 muta- 
tion to the region between the BglII and PstI sites, assuming 
a linear relationship between the degree of truncation and the 
mobility of the protein on SDS-polyacrylamide gels. A  fur- 
ther truncation  to the EcoRV site within  SEC8 results in a 
loss of complementing activity (Fig.  1 a). 
Sec8p Is Located on Both  the Plasma Membrane  and 
in a Soluble Particle 
To determine the subcellular localization of Sec8p differen- Figure  3.  Identification  and 
localization  of  Sec8p  using 
TrpE-Sec8 fusion protein gen- 
erated polyclonal antibody. A 
glass  bead  lysate  of  NYI3 
cells was analyzed by immu- 
noblot analysis using the anti- 
Sec8  polyclonal  antiserum. 
This  antiserum  recognizes a 
protein of ,,o122 kD (lane 2) 
indicated by the arrow on the 
left. To verify that this protein 
is Sec8p we introduced pNB- 
328, a high copy number plas- 
mid containing the SEC8 gene 
into  NY13 ceils  to overpro- 
duce  the  Sec8  protein.  The 
122-kD band is amplified in 
this lysate (lane 1) and several 
bands appear that may corre- 
spond to degradation  products. 
The Sec8-9 mutant protein identified in a secS-9 lysate has an apparent molecular weight of 82 kD (lane 6) indicated by the arrow on 
the right. In lanes 3-5 we transformed sec8-9 cells with plasmids containing opal, amber, and ochre tRNA suppressor genes. Cells contain- 
ing the opal tRNA suppressor gene (lane 3) produce full-length Sec8p. In lanes 7-9 WT, sec8-9 cells containing the opal tRNA suppressor 
gene, and sec8-9 cells were incubated at 37~  and analyzed by immunoblot analysis with anti-Sec8 antibody. 
tial centrifugation was carried out on wild-type yeast cell ly- 
sates  and  immunoblot  analysis  performed  using  affinity 
purified anti-Sec8 antibody. Approximately 21% of the total 
cellular Sec8p is found in a 10,000 g membrane pellet (Table 
V). Centrifugation of the 10,000 g supernatant at 100,000 g, 
pellets an additional  33%  of the cellular  Sec8p.  The re- 
mainder is located in the 100,000 g supernatant (Table V). 
To determine the membrane component with which Sec8p 
is associated in the  10,000 g pellet, we performed sucrose 
gradient fractionation. A  10,000 g  pellet from NY13 cells 
was resuspended in 55 % sucrose and overlaid with a  step 
gradient  made  by  addition  of various  sucrose  solutions 
decreasing in concentration to 30%. After centrifugation to 
equilibrium, the gradient was fractionated and aliquots were 
subjected  to  SDS-gel  electrophoresis  and  transferred  to 
nitrocellulose. The Sec8p present in each fraction was quan- 
titated using  o~Sec8p antibody and  125I-protein A,  and the 
results were expressed as the CPM specifically bound per 50 
#1 of fraction. 
The profile of a  typical 10,000 g  sucrose gradient from 
wild type cells is shown in Fig. 4. Sec8p co-fractionates with 
both the plasma membrane marker enzyme, vanadate sensi- 
tive Mg2+-ATPase  activity, and Secl5p. During differential 
centrifugation we typically observe 50-60% of the total cel- 
lular plasma membrane ATPase activity associated with the 
Table It. Percent of Sec8 Localized in Subcellular 
Fractions of  NY13 Cells 
Total lysate  $2  P2  $3  P3 
100%  86  21  39  33 
Subeellular fractionation of NY13 cells and localization of secSp by quantita- 
tive immunoblot analysis using anti-Sec8 antibody. NY13 cells were osmoti- 
c.ally lysed and centrifuged at 450 g  for 3  min.  The supernatant was then 
centrifuged al  10,000 g  for  10 min to form $2 and P2.  The S2 was further 
centrifuged at  100,000 g  for 60 min to form $3 and P3.  Each fraction was 
quantitated for SecSp  and the results expressed as the percentage of the total 
lysa~ tt'l~q-l~hown  are the average of five independent experiments. 
10,000 g pellet. Approximately 20% of the ATPase activity 
is associated with the 100,000 g membrane pellet while the 
activity remaining in the soluble fraction is attributed to in- 
terfering  ATPases.  Sec8p  does  not  co-fractionate  with 
NADPH-cytochrome c reductase activity, a marker for the 
ER (Kreibich et al., 1973). Sec8p also fails to co-fractionate 
with a marker for the yeast Golgi apparatus (Abeijon et al., 
1989),  GDPase activity (Fig.  4  c).  We typically observe 
40-45%  of the total GDPase activity associated with the 
10,000 g pellet. From this result we conclude that the Sec8p 
found in a 10,000 g pellet from wild type cells is associated 
with the plasma membrane. 
We next determined if the pool of Sec8p that pellets at 
100,000 g is associated with a membrane. It is possible that 
Sec8p associates with small membrane bounded organelles, 
such as secretory vesicles, that are found in a  high speed 
(100,000 g) pellet of a yeast lysate. Alternatively, Sec8p may 
be  a  component of a  proteinaceous particle  and  not  as- 
sociated with a membrane. To address these possibilities su- 
crose density gradient fractionation was performed using a 
100,000 g  pellet derived from wild-type yeast cells. Sec8p 
did not float into the gradient with membrane components 
but remained at the bottom of the gradient with free protein 
(data not shown). 
Since few secretory vesicles are present in wild type yeast 
cells, we determined if Sec8p was associated with the en- 
larged pool of  secretory  vesicles isolated by Sephacryl S-l,000 
gel filtration chromatography from the late-acting sec mu- 
tant  NY17  (sec6-4)  (Walworth and  Novick,  1987).  NY17 
cells were incubated at the restrictive temperature (37~  for 
1 h and simultaneously shifted into low glucose containing 
media to derepress synthesis of the secretory protein inver- 
tase.  Thus  invertase  can  be  used  as  a  lumenal  enzyme 
marker for secretory vesicles. Each fraction eluted from the 
column was assayed for marker enzymes and for the abun- 
dance of Sec8p by immunoblot analysis. The results of this 
fractionation  indicate  that  Sec8p elutes  from the  column 
with the leading edge of free protein (Fig. 5 a) and is not as- 
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Figure 4. Localization of Sec8p and organelle  enzyme marker ac- 
tivities in sucrose gradient fractions of a 10,000 g membrane pellet 
from NY13 cells. A 10,000 g pellet was resuspended in 2 ml of 55 % 
sucrose, 10 mM MES pH 6.5 and placed at the bottom of a 30-55 % 
sucrose gradient. After centrifugation to equilibrium,  the gradient 
was fractionated and aliquots of each fraction analyzed for Sec8p, 
plasma membrane ATPase, Secl5p, cytochrome c reductase,  GDP- 
ase, and sucrose density. (A) Sec8p and plasma membrane ATPase 
co-fractionate within the gradient. Sec8p was quantitated  from im- 
munoblots by determination of I25I-Protein A secondary antibody 
on cut out strips of nitrocellulose  and expressed  as the number of 
125I counts per 50 #l of each fraction (--~-). The recovery of Sec8p 
from the gradient was 87 % of the loaded pellet  fraction. Plasma 
membrane ATPase activity was determined by measuring the re- 
lease of inorganic  phosphate for 10 min at 37~  and the result ex- 
pressed as the nmoles of liberated  phosphate per fraction per min 
(-4:3-). (B)  The gradient profiles  of Sec15p  (--I-), quantitated  in 
each fraction by immunoblot analysis as above, and cytochrome c 
reductase activity (-o-).  The cytochrome c reductase activity is 
expressed  as the rate of increase in the A550,m  of the enzyme reac- 
tion using 20 #1 of each fraction. (C) Localization of GDPase (-~-) 
within the gradient, expressed as the nmoles of liberated phosphate 
per fraction per min using 30 #l of each fraction. (-i-) Percent su- 
crose of each fraction. Fraction 1 is the gradient pellet and fraction 
19 is the top of the gradient. 
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Figure 5. SecSp is not associated  with isolated  secretory vesicles 
from a  100,000 g pellet from NY17 cells.  The pellet was resus- 
pended in 1 ml of lysis buffer and analyzed by Sephacryl S-1000 
gel filtration.  (A) SecSp (--e-) was localized in the column fractions 
by quantitative  immunoblot analysis  as described in Fig. 4. The 
recovery of Sec8p from the column was 94 %. The protein concen- 
tration of each fraction was determined by Bradford analysis (--~-). 
(B) Markers for secretory vesicles (--m-), expressed  as the #mol of 
glucose released per fraction per min, and Secl5p (-o-). (C) Elu- 
tion profiles of GDPase (-~-) and Kex2 (--A--). The Kex2 activity is 
expressed  as the units  of latent  Kex2 activity per 50 #1 of each 
fraction. 
sociated with secretory vesicles (Fig. 5 b) or other identified 
organelles (Fig. 5 c). This elution profile is identical to that 
observed with  Secl5p  (Fig.  5  b;  and Bowser and Novick, 
1991). These results suggest that the pool of Sec8p that is not 
associated with the plasma membrane is a component of a 
soluble protein aggregate or complex. 
Soluble SecSp Is Found in a High Molecular 
Weight Particle with Properties Identical to That of 
Soluble Secl5p 
To further characterize the soluble pool of Sec8p, Sephacryl 
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Figure 6.  The stability of the soluble complex containing  Sec8p 
and Secl5p is affected by mutations in the SEC8 or SEC15 genes. 
10,000 g supernatants  from wild type, secS-9, and sec15-1 cells 
were analyzed by Sephacryl S-500 gel filtration. The column frac- 
tions were analyzed for the presence of Sec8p and Secl5p by quan- 
titative immunoblot analysis and expressed as the number of 1251 
secondary antibody counts (cpm) per 50 #1 of each fraction.  The 
protein concentration of each fraction was determined by Bradford 
analysis. (A) Gel filtration of NY13 supernatant.  1 ml of a 20 mg/ml 
10,000 g supernatant  was loaded on the column and analyzed for 
the elution profile of Secgp (--i-) and Secl5p (--o-). The recovery 
of Sec8p from the column was 65 % and the recovery of Secl5p was 
60%.  Vertical arrows,  from left to right,  mark the  position  of 
thyroglobulin (669 kD),/~-amylase (200 kD), and BSA (66 kD). 
(B) Gel filtration of a supernatant  from secS-9 cells. The elution 
profile of the scc8-9 mutant protein shifts to fractions 53-54 (--i-) 
and reduced  levels of Seel5p elute from the column  (-o--). The 
recovery of the mutant Soc8-9 protein from the column was 95 %. 
(C) Gel filtration of a supernatant  from sec15-1 cells. Sec8p fails 
to elute from the column in fractions 47-48 as in wild type cells. 
The recovery of See8p from the column was 29%. 
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Figure 7. Soluble Sec8p is associated with a 19.5Sparticle identified 
by sucrose velocity gradient centrifugation of a 10,000 g superna- 
tant of NYll cells. Sec8p (--[3-) and Secl5p (--o-) were localized in 
each  fraction  by  immunoblot  analysis  and  the  sedimentation 
coefficient of both Sec8p and Secl5p was found to correspond  to 
a value of 19.5S. The recovery of Secgp and Seel5p in the gradient 
fractions was 93 and 91%, respectively. Vertical arrows, from left 
to  right,  mark the  position  of thyroglobulin  (19.5S),  catalase 
(11.3S), and BSA (4.5S). 
S-500 gel filtration of a  10,000 g  supernatant from NY13 
cells was performed. This supernatant contains all Sec8p not 
associated with the plasma membrane. The resulting column 
fractions were analyzed by immunoblot analysis for SecSp 
and Secl5p as described. We observe that Sec8p co-elutes 
with  Secl5p in a  single peak with an apparent molecular 
mass of 1,000-2,000  kD (Fig.  6 a). No monomer form of 
Sec8p is apparent. This high molecular mass particle con- 
taining Sec8p is stable to treatment with 500 mM NaC1 dur- 
ing the column fractionation (data not shown), as in the case 
of Secl5p (Bowser and Novick,  1991). 
Previous  results  demonstrated  that  the  soluble  particle 
containing Secl5p has a  sedimentation coefficient of 19.5S 
(Bowser and Novick, 1991). To determine the sedimentation 
coefficient of soluble  Sec8p  a  10,000  g  supernatant  from 
NY13 cells was analyzed by sucrose velocity gradient cen- 
trifugation. As shown in Fig. 7, the soluble particle of Sec8 
also has a sedimentation coefficient of 19.5S.  Therefore the 
soluble pool of Sec8p has properties identical to those of 
soluble Secl5p. 
Sec8p and SeclSp Associate in a Protein Complex 
The results shown above suggest that Sec8p and Secl5p may 
each be a  component of a  soluble high molecular weight 
complex. To directly determine if Sec8p and Secl5p are as- 
sociated  with  each  other  we  attempted  to  co-precipitate 
Secl5p with anti-Sec8 antibody. A 10,000 g supernatant was 
prepared from wild-type, protease deficient cells (NY580) 
and immunoprecipitations were performed either under na- 
tive conditions without prior cross-linking or under denatur- 
ing conditions after treatment with the thiol-reversible cross- 
linking  agent  DSP.  If present,  the  cross-linker  was  then 
cleaved by reduction  and  the proteins  evaluated by SDS- 
PAGE and immunoblot analysis using anti-Sec8  and anti- 
Secl5 antibodies. 
The anti-Sec8  antibody (aSec8p)  successfully immuno- 
precipitates Sec8p under native conditions  (Fig.  8).  How- 
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Secl5p by immunoprecipitation  with anti-See8 antibody. A 10,000 g 
supernatant from NY580 cells was incubated in the absence (lanes 
1 and 6) or presence of the chemical crosslinker DSP for 30 min 
at 4~  Lanes 2 and 7 contain 1 mM DSP and lanes 4 and 9 were 
treated with 2 mM of previously inactivated DSP.  Lanes 3 and 8, 
samples were treated with 2 mM DSP. Cross-linking reactions were 
quenched  and  subjected to  immunoprecipitation with  8  /~g  of 
affinity  purified anti-See8 IgG. Within a yeast lysate  the control IgG 
recognizes several proteins by immunoblot analysis. Lanes 5 and 
10, samples were immunoprecipitated with 8 ~g of a control rabbit 
anti-mouse  IgG.  (A)  Immunoprecipitated  Sec8p  and  Secl5p 
identified by immunoblot analysis using affinity purified anti-See8 
(left) and anti-Secl5 (right) antibodies. (B) Quantitative determina- 
tion of Sec8p and Secl5p from cut out nitrocellulose strips of A. 
(C) Hexokinase and Sec6p are not precipitated with anti-See8 IgG. 
Samples were treated with 2  mM DSP and immunoprecipitated 
with anti-See8 IgG. The resulting pellet and supernatant were ana- 
lyzed for hexokinase and Sec6p localization by immunoblot analy- 
sis. Hexokinase immunoreactivity remains in the supernatant (lane 
1) and fails to precipitate with anti-See8 antibody (lane 2). Overex- 
posure of the blot confirms these results (lanes 3 and 4). Lanes 1 
and 2 are from a  l-h exposure of the blot, lanes 3 and 4 are from 
a 3-h exposure. The arrows indicate the locations of the molecular 
mass standards. They are from top to bottom: phosphorylase B, 
97.5  kD; BSA, 66 kD; ovalbumin, 45 kD. 
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are associated in a complex on 
the plasma membrane and can 
be released  from the membrane 
in a complex. A plasma mem- 
brane containing  pellet was iso- 
lated from  NY13 cells. In lanes 
1-3 and 5-7 we incubated the 
membrane  in  lysis  buffer at 
pH 8.0 for 2 h. The sample was 
then centrifuged at  10,000 g 
for 10 min to pellet the mem- 
brane.  The  supernatant  was 
removed and analyzed as fol- 
lows.  In  lanes  1  and  5  the 
supernatant was  immunopre- 
cipitated  with  a  rabbit  anti- 
mouse control IgG. Sec8p and 
Secl5p fail to precipitate in the 
presence of  the control IgG. In 
lanes 2 and 6 the supernatant 
was  cross-linked  with  DSP 
and immunoprecipitated with 
anti-Sec8 antibody. In lanes 3 
and 7the supernatant was im- 
munoprecipitated with anti-See8 antibody in the absence of DSP. In lanes 4 and 8 the membrane pellet was washed once with lysis buffer 
and centrifuged. After resuspension in 50 #1 of lysis buffer, the sample was crosslinked with DSP. Upon solubilization of the membrane 
with SDS, we immunoprecipitated with anti-Sec8 antibody. For all samples we performed immunoblot analysis of  the precipitate and probed 
for SecSp (left) and Secl5p (right). 
ever, very little Secl5p was precipitated using these condi- 
tions. By quantitative immunoblot analysis 30% of the total 
Sec8p and 0.2% of the total Secl5p in the 10,000 g superna- 
tant precipitated by native immunoprecipitation. Treatment 
with DSP (0.02 and 0.04 vol of a 20 mg/ml stock) and pre- 
cipitation under denaturing conditions resulted in increased 
amounts of precipitable Secl5p (5-6 % of the total), with no 
change in the level of Sec8p precipitation (Fig. 8). Addition 
of DSP above 0.04 vol decreased the level of immunoprecipi- 
tation of both SecSp and Secl5p.  Prior inactivation of the 
cross-linker by incubation with DTT resulted in a  loss of 
Secl5p precipitation, to levels precipitated under native con- 
ditions,  indicating  that  Secl5p precipitation is  dependent 
upon cross-linking. As a control, immunoprecipitation was 
performed with a control rabbit IgG, using identical quanti- 
fies of  IgG that were present in the anti-Sec8 immunoprecipi- 
tations. The control IgG failed to precipitate either Sec8p or 
Secl5p (Fig.  8). 
As an additional control for nonspecific precipitation in 
the  presence  of cross-linker,  we  performed  immunoblot 
analysis with both anti-hexokinase and anti-Sec6 antibodies 
after  immunoprecipitation  with  anti-Sec8  antibody.  As 
shown  in  Fig.  8  c,  hexokinase  fails  to  precipitate  with 
otSec8p antibody and remains soluble. Overexposure of the 
labeled blot also failed to detect hexokinase immunoreac- 
tivity in the precipitated fraction. Sec6p is a soluble protein 
implicated  in  transport  from the  Golgi  apparatus  to  the 
plasma membrane that sediments on sucrose velocity gra- 
dients more slowly than the Sec8p/Secl5p complex (Potenza 
et al., 1992). Sec6p also fails to precipitate (data not shown). 
As previously discussed,  21%  of the cellular Sec8p and 
25 % of Secl5p are associated with the plasma membrane 
(Fig. 4). It is possible that Sec8p and Secl5p associate with 
the plasma membrane in a complex or independently. To ex- 
amine these possibilities a  10,000 g membrane pellet from 
NY580 cells was resuspended in lysis buffer, treated with 
DSP, and solubilized with SDS. Proteins were immunopre- 
cipitated  with  otSec8p  antibody.  The  results  show  that 
Secl5p from the membrane fraction can be co-precipitated 
with Sec8p after treatment with cross-linker (Fig. 9, lanes 4 
and  8).  This data suggests that Sec8p and Secl5p are as- 
sociated with each other in a complex on the plasma mem- 
brane, as they are in the soluble fraction. 
We have previously demonstrated that Secl5p can be re- 
moved from the plasma membrane by treatment with 0.5 M 
NaC1 at high pH (Bowser and Novick,  1991),  and that the 
released Secl5p has an apparent molecular mass of 1,000 kD 
by gel filtration. These conditions were used to determine if 
Sec8p also can be released from the plasma membrane. A 
10,000 g  pellet from NY13  cells was incubated with lysis 
buffer, pH  8.0, containing 500 mM NaC1  for  1 h  and the 
membrane was then repelleted. The supernatant was assayed 
for the presence of Sec8p by immunoblot and also analyzed 
by gel filtration. Sec8p was found to be released from the 
plasma membrane and co-elute with Secl5p in a soluble par- 
ticle of 1,000 kD (data not shown). 
Since both Sec8p and Secl5p can be extracted from the 
plasma membrane by high pH treatment and then co-elute 
by gel filtration, we attempted to co-precipitate the released 
Secl5p with otSec8p antibody. A 10,000 g pellet from NY580 
cells was incubated in lysis buffer at pH 8.0 for 2.5 h on ice. 
The sample was then centrifuged at 10,000 g for 10 min to 
repellet the membrane.  The supernatant was removed and 
used for immunoprecipitation with or without prior cross- 
linking  as  described above.  The results  show that  Secl5p 
released  from the  plasma  membrane  is  precipitated with 
otSec8p antibody after crosslinking (Fig. 9). Immunoprecip- 
itation in the presence of a control IgG failed to precipitate 
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complex containing both Sec8p and Secl5p can be disso- 
ciated from the plasma membrane. 
The Stability of the Complex Is Affected by Mutations 
in Either SEC8 or SEC15 
The stability of protein complexes is often adversely affected 
by defects in one of the components. To further probe the in- 
teraction of Sec8p and Sec15p we determined if the size or 
stability of the Sec8p/Secl5p complex could be affected by 
mutations in either gene. S-500 gel filtration chromatogra- 
phy was performed on 10,000 g supernatants derived from 
wild type, secS-9,  and sec15-1 cells. Equal amounts of pro- 
tein were loaded onto the column and quantitative immuno- 
blot analysis was performed on aliquots of each fraction to 
determine the location and quantity of Sec8p, Secl5p, and 
the mutant proteins. 
As shown in Fig. 6 a, Sec8p and Secl5p co-elute by S-500 
gel filtration of a  supernatant derived from NY13  (SEC8, 
SEC15) cells. However, upon fractionation of a supernatant 
from secS-9 cells  greatly  reduced  levels  of Secl5p  were 
found to elute from the column, and no distinct peak was 
seen (Fig. 6 b). Degradation products of Secl5p were present 
on the nitrocellulose blot. We also found that the truncated 
Sec8-9 protein did not elute in fractions 4%49 as in the wild 
type column profile, but instead eluted in fractions 53-54 
(Fig. 6 b), corresponding to an apparent molecular mass of 
200 kD. These data suggest that the sec8-9 mutation results 
in a partial disruption of the soluble particle, and that in re- 
sponse to this disruption,  Secl5p is destabilized. 
Analysis of a supernatant from sec15-1 cells by gel filtra- 
tion revealed that the level of Sec8p was reduced in the elu- 
tion  profile  of  this  mutant  supernatant  and  distributed 
throughout the profile, rather than concentrated in fractions 
47-49 (Fig. 6 c). Detection of the mutant Secl5-1 protein by 
immunoblot was problematic due to its low abundance and 
the presence of a cross-reacting protein of similar mobility. 
To  determine  if the  instability  of Sec8p  or  Secl5p  was 
specific to mutations in either the SEC15 or SEC8 genes, gel 
filtration chromatography of a supernatant derived from an- 
other late-acting sec mutant, sec6-4,  was carried out. In this 
column profile both  Sec8p  and  Secl5p  elute  in  fractions 
47-49 as in the case of a wild-type column profile (data not 
shown). 
These results indicate that the stability of the soluble com- 
plex is affected by mutations in either SEC8 or SEC15. The 
observed instability of the soluble complex in these mutant 
lysates may reflect an overall decrease in the amount of com- 
plex present in vivo, or decreased stability during column 
fractionation. Since it is possible that dilution of the superna- 
tant may affect the degree of instability of the proteins in mu- 
tant lysates, we made dilutions of each supernatant to 0.5 
mg/ml  to  approximate  the  concentration of protein  after 
column fractionation and incubated them at 4~  for 3 h, the 
time it takes to perform the column fractionation. Both the 
starting material and the diluted material were analyzed after 
incubation for Sec8p and Secl5p by quantitative immuno- 
blots.  These  values  were  expressed  as  the  CPM  of ]25I- 
Protein A bound per mg of protein. 
The supernatants of wild type, sec8-9, sec15-1, and sec6-4 
cells contained similar quantities of Sec8p and Secl5p (Fig. 
10, solid bars). However upon subsequent dilution and incu- 
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Figure 10. The stability of Sec8p and Secl5p is affected by sec8-9 
and sec15-1 mutations but not by a sec6-4 mutation. 10,000  g super- 
natants were prepared from NY13 (SEC8, SEC15), NYI7 (sec6-4), 
NY410 (sec8-9), and NY64 (sec15d) cells. All supernatants had 
a protein concentration of  20 mg/ml. Equal volumes of each sample 
were analyzed by immunoblot analysis either immediately (I) or 
after dilution in lysis buffer to 0.5 mg/ml and incubation at 4~  for 
3 h ([]). The samples were probed for Sec8p (A) or Secl5p (B). 
The results, normalized for protein concentration, represent the av- 
erage of two to four independent experiments and standard devia- 
tions are shown. 
bation, the level of Sec8p decreased in the supernatant de- 
rived from sec15-1 cells (Fig.  10 a, hatched bars), but not 
in the supernatants derived from wild type ceils or sec6-4 
cells. Approximately 98-100% of the Sec8p present in the 
diluted wild type or sec6-4 lysate was present after 3 h at 
4~  whereas only 53 % of Sec8p in a diluted sec15-1 lysate 
remained. Likewise, the stability of Secl5p was decreased in 
sec8-9 cells (Fig.  10 b). Only 38% of the Secl5p contained 
in a diluted sec8-9 lysate remained after a 3-h incubation at 
4~  The stability of Secl5p was unaffected in sec6-4 cells, 
consistent with the gel filtration results. These data indicate 
that the stability of  the complex containing Sec8p and Secl5p 
is  influenced in vitro by mutations  in either the SEC8 or 
SEC15 genes. 
Sec8p May Interact With Sec4p 
As the amino terminus of Sec8p is similar in sequence to the 
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Figure 11. Sec4p co-elutes with the SecSp/Secl5p complex by gel 
filtration. 10,000 g supernatants from NY13 (SEC8, SEC15), NY17 
(sec8-9),  and NY64 (seal54) cells were analyzed by Sephacryl 
S-500 gel filtration and the fractions assayed for the presence of 
Sec8p and Sec4p by quantitative immunoblot analysis. The results 
are expressed as the amount of 125I-Protein A (cpm) specifically 
bound per sample. (A) Column fractionation of 20.5 mg of a NYI 3 
supernatant. SecSp (--E3-) elutes in a single peak as observed in 
Fig. 9. Sec4p (--e-) elutes in two distinct peaks. The recovery of 
SecSp from the column was 97%. Vertical arrows, from left to 
right, mark the location of  thyroglobulin  (669 kD),/~-amylase (200 
kD), and BSA (66 kD). (B) S-500 gel filtration of 20.5 mg of a 
sec8-9 supernatant. The secS-9 protein (<3-) and Sec4p (--o-) elu- 
tion profiles are shown. The recovery of secS-9 protein from the 
column was 95% and the recovery of Sec4p was 50%. (C) S-500 
gel filtration of 20.5 nag of a sed54  supernatant. Sec8p (-c3-) 
and Sec4p (+)  elution profiles. The recovery of Sec8p from the 
column was 40%  and the recovery of Sec4p from the column 
was 70%. 
region of yeast adenylate cyclase implicated in interaction 
with RAS (Fig. 2 b), we determined if Sec8p may associate 
with Sec4p, the member of  the ras superfamily that functions 
in post-Golgi transport. It has been previously shown that 
Sec4p cycles between the plasma membrane and secretory 
vesicles through a soluble intermediate (Goud et al., 1988). 
Since the Sec8p/Secl5p complex is also associated with the 
plasma membrane and found in the cytoplasm, Sec8p could 
associate with Sec4p in either location. 
To determine if Sec4p associates with the soluble complex 
containing Sec8p,  Sephacryl S-500  gel filtration chroma- 
tography of a 10,000 g supernatant derived from NY13 cells 
was performed and fractions quantitated for both Sec4p and 
SecSp  by  immunoblot  analysis.  SecSp  elutes  from  the 
column in  a  single peak  (Fig.  11  a),  as  was previously 
demonstrated. Sec4p elutes from the column in two distinct 
peaks (Fig. 11 a). The first peak co-elutes with Sec8p while 
the second elutes with an apparent molecular mass of 60-70 
kD. Integration of the two peaks indicates that ~20% of the 
eluted Sec4p co-fractionates with the peak of Sec8p, suggest- 
ing that a  portion of the total cellular Sec4p may be as- 
sociated with the complex containing Sec8p. 
It is also possible that Sec4p associates with another high 
molecular weight particle or protein aggregate that coinci- 
dently elutes at the position of the Sec8/Sed5p complex. As 
shown in Figs. 6 and 10, the complex containing Sec8p and 
Sec15p  becomes unstable in sec8-9 or secl5-1  lysates.  If 
Sec4p is associated with this complex then the initial peak 
of Sec4p should also be sensitive to mutations in SEC8 and 
SEC15. Therefore we carried out gel filtration chromatogra- 
phy of cytosol derived from sec8-9 and sec154 and localized 
Sec4p. 
As shown in Fig. 11 b, the initial peak of Sec4p is not seen 
in the elution profile of a sec8-9 lysate. The 60-70-kD pool 
of Sec4p is somewhat enlarged, possibly due to release of 
Sec4p  from the Sec8p/Secl5p  complex and incorporation 
into the 60-70-kD  pool.  The Sec8-9  mutant protein that 
elutes in fractions 51-54 may also retain the ability to inter- 
act with Sec4p. 
A sec15-1 lysate was next analyzed by S-500 column frac- 
tionation. Again the initial peak of Sec4p was absent and the 
60-70-kD pool was enlarged relative to that of a wild type 
lysate (Fig. 11 c). These results suggest that a portion of the 
soluble pool of Sec4p is in association with the Sec8/Sec15p 
complex, and under conditions that render the Sec8p/Sec15p 
complex unstable, this pool of Sec4p is not detected. This 
result  supports  the  hypothesis  that  Sec8p  interacts  with 
Sec4p. 
Discussion 
We  have  shown  that  the  SEC8  gene  encodes  a  122-kD 
hydrophilic protein that functions, together with the Secl5 
protein, in a  19.5S complex that can peripherally associate 
with the plasma membrane. Several lines of evidence suggest 
that this complex may serve as the downstream effector of 
Sec4p to regulate vesicular transport from the Golgi appara- 
tus to the cell surface in yeast cells. 
The first line of evidence is based on the strong genetic in- 
teractions seen among mutants defective in the SEC4, SECS, 
and SEC15 genes. These are three members of a set of late- 
acting sec mutants that display synthetic lethality in combi- 
nation with one another (Salminen and Novick, 1987).  The 
growth defects of these mutants are partially suppressed by 
a twofold increase in the expression of SEC4. This genetic 
evidence cannot, by itself, establish that physical interac- 
tions occur between the gene products. It does, however, sug- 
gest that the encoded proteins are acting in a concerted fash- 
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pathway in which they function. 
Biochemical evidence suggests a direct,  physical  interac- 
tion of Sec4p with the Sec8p/Secl5p complex. Analysis of 
a soluble fraction derived from wild type cells by gel filtra- 
tion indicated  that a portion of Sec4p co-elutes with the 
Sec8/Secl5p complex (Fig. 11). The presence of this species 
of Sec4p was found to be sensitive to mutations in either 
SEC8  or SEC15  (Fig. 11), supporting a model in which Sec4p 
directly  associates with the Sec8p/Secl5p complex. 
Sequence analysis of SEC8 may provide a clue to the na- 
ture of the proposed interaction  of Sec4p with the Secgp/ 
Secl5p complex. A 202 amino acid region of Sec8p shares 
25 % sequence identity  with the region of yeast adenylate 
cyclase  that is necessary  for Ras  responsive regulation  of 
cAMP synthesis (ColiceUi  et al.,  1990; Field et al.,  1990). 
This region of cyclase may make direct contact with the Ras 
protein.  The  observed  sequence  similarity  suggests  that 
Secgp could have an analogous relationship to Sec4p as ade- 
nylate cyclase has to Ras, i.e., Sec8p may be the downstream 
effector of Sec4p.  Since Sec4p is only 32% identical  in se- 
quence to Ras (Salminen and Novick, 1987) it is not surpris- 
ing that Sec8p and adenylate  cyclase  do not exhibit a high 
degree of similarity. Nevertheless, since Sec8p and adenylate 
cyclase share a relatively low level of sequence identity, fur- 
ther biochemical evidence will be necessary to establish this 
analogy. 
Some insight into the function of the See8p/Secl5p protein 
complex can  be  gained  from the  subeellular  localization 
data. Approximately 20-25 % of the Sec8p/Secl5p complex 
was  associated  with  the  plasma  membrane,  and  the  re- 
mainder was found to be soluble. The Sec8p/Secl5p complex 
was released from an isolated plasma membrane fraction by 
a salt wash (0.5 M NaC1, pH 8.0) indicating peripheral mem- 
brane attachment.  The association of the complex with the 
plasma membrane therefore, may be mediated by an ionic in- 
teraction with a membrane protein. See4p itself, could serve 
as the attachment site for the SecSp/Secl5p complex, since 
the major pool of Sec4p is tightly associated with the cyto- 
plasmic face of the plasma membrane.  However,  if Sec4p 
serves as the attachment site, there must be additional levels 
of regulation as well, because secretory vesicles carry Sec4p 
but do not carry Sec8p or Sec15p. Furthermore, see4-8 mu- 
tants are not altered in their distribution of Sec8 and Secl5 
(R. Bowser, unpublished observation).  One interesting pos- 
sibility is that the complex containing Sec8p and Secl5p nor- 
mally cycles between the plasma membrane and the cyto- 
plasm in conjunction with vesicle docking or fusion events. 
The 19.55 Sec8p/Sec15p complex may contain additional 
subunits.  Candidates for such components are the products 
of the other genes that interact with SEC4, SECS, and SEC15. 
Sec8p and Secl5p may be in direct contact with each other, 
or they may interact through intervening  subunits.  Deeper 
insight into the structure of the complex and a detailed  un- 
derstanding of the proposed interaction with See4p will re- 
quire purification of the native complex. These goals will re- 
quire the development of more specific reagents. 
A combination of genetic and biochemical analysis has un- 
covered a complex containing  Sec8p and Secl5p that func- 
tions at the final step of the secretory pathway, possibly in 
response to Sec4p function. Since there are numerous Sec4p 
homologs that regulate different stages of the exocytotic and 
endocytic pathways (Chavrier et al., 1990a,b; Gorvel et al., 
1991; Johnston et al.,  1991), additional complexes contain- 
ing subunits analogous and possibly homologous to Sec8p 
and Secl5p may be present in yeast and animal cells serving 
to respond to distinct members of the SEC4/Ytrll/rab family 
of GTP-binding  proteins. 
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